Monthly Metrics Forum February 2014 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection.

Slides:



Advertisements
Similar presentations
1 Proprietary and Confidential 1 Identification of Potentially Avoidable Emergency Department Visits Using Claims Data APHA Session : Advances in.
Advertisements

Multi-Payer Reimbursement Pilot Overview of Risk/Benefit to Practices L Gordon Moore MD.
MHSPHP Metrics Forum Antidepressant Medication Management And
Present on Admission. Requirements of Deficit Reduction Act 2005 CMS and CDC choose conditions that are: High Cost, High Volume, or both. Assigned to.
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Azara Proprietary & Confidential Cervical Cancer Screening 2014 Measure Changes Improving Patient Outcomes through Data.
The Military Health Service Population Health Portal (MHSPHP) in Carepoint Judy Rosen, MSN, RNC Nurse Informaticist, WT Inc AFMSA/SG6H
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
PEBB: 1/18/05Prepared by Aon Consulting1 Chronic Disease Management 2003 Annual Report-Highlights PEBB Board Meeting 1/18/05 BD attach. 5.
MHSPHP Metrics Forum Diabetes
1 Sheryl Hurt AFMC Provider Representative Episodes of Care AFMC has partnered with the initiative to provide communication design and printing.
Quality in Laboratory Medicine Conference Business Case for Quality Recognizing Excellence in Practice Presented to the Institute for Quality in Laboratory.
Lori Andersen Asst. Director, Policy Measures HEDIS 2014 Code Transition.
Steven M. Wright, PhD Director of Epidemiology Office of Quality and Performance An Analysis of the Quality of Care Provided to Men and Women in the VA.
Performance Measures 101 Presenter: Peggy Ketterer, RN, BSN, CHCA Executive Director, EQRO Services Health Services Advisory Group June 18, :15 p.m.–4:45.
Harnessing the Power of Predictive Modeling Future Trends.
New York State Health Homes Phase I Implementation Update Statewide Webinar Presented by: New York State DOH November 7,
{ Louisiana Medicaid Baseline Quality Data Dr. Sandra Blake Eddy Myers University of Louisiana at Monroe College of Pharmacy Office of Outcomes Research.
Wendy Talbot MPH, CHCA Project Manager, Audits Validation and Analysis of Performance Measures and Results for all MCOs.
1 Presentation to:Care Management Committee Presented by: Janice Carson, MD Deputy Director, PQO Date: 04/09/15 Performance Measurement.
Delaware Community Health Access Program (CHAP): Evaluation of Referrals and Health Outcomes James M. Gill, MD, MPH Christiana Care Health Services August.
Putting the Pieces Together – GPRA, CRS and Education Mary Wachacha 2010.
MHSPHP Metrics Forum Obesity May 2013
All Blue 2014 Workshop. The Effects of ACA on Cover Tennessee CoverTN – Ended Dec. 31, Provider service line remains open ( ) 2.Timely.
Performance Measurement Sets Dolores Yanagihara Program Development Manager IHA.
Ambulatory Care Quality Measures: Disease Management Research Opportunities Neil Goldfarb Director of Research and Research Assistant Professor of Health.
1 Western New York Quality Measurement Collaborative.
Vaginal Pap smear codes and Hysterectomy Exclusions And MHSPHP 3G updates.
Utah Emergency Medical Service Discharges Attributed to Opiate Use For Record Years
LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.
Page 1 External Quality Review Quarterly Meeting Monday, March 21, :00 p.m. –2:30 p.m. WELCOME!
What does the Future Have in Store? The Roadmap for Phase 2 of C4K Ruth S. Gubernick, MPH Quality Improvement Advisor Florida Pediatric Medical Home Demonstration.
Measuring the Occurrence of Disease 1 Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State.
BlueCross BlueShield of Tennessee, Inc., an Independent Licensee of the BlueCross BlueShield Association. This document has been classified as public Information.
11 Physician Web Portal Project Quality Measures Initiative January 2010.
Performance Measures 101 Presenter: Peggy Ketterer, RN, BSN, CHCA Executive Director, EQRO Services Health Services Advisory Group March 28, :00.
Information Technology and Data Collection: February 28, 2008 Optimizing Lab Results and Pharmacy Data Collection Under P4P Concurrent Session 1.07 Horace.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
Overview of HMO HEDIS 2006 Results 11:00 a.m.–11:30 a.m. March 28, 2007.
Antidepressant Medication Management Updates (CMS128) Change Review Process Meeting November 19, 2015 Jenna Williams-Bader Anne Marie Smith Stephanie Rodriguez.
MHSPHP Metrics Forum July 2013
Emanuel Medical Center Case Management By: Deadre Hadden, RN.
Cost Effectiveness of Allergy Care. Asthma Patients Cared for by Allergists Have: Fewer emergency care visits Fewer hospitalizations Reduced length of.
2 nd Thursday of the Month MHSPHP Metrics Forum Asthma September 2013
Use of EHR & Quality Based on Zhou, et al. The Relationship between Electronic Health Record Use and Quality of Care over Time. J Am Med Inform Assoc.
1 DESIGNING HEALTH in VIRGINIA: VIRGINIA as the HEALTHIEST STATE IN THE NATION Marissa J. Levine, MD MPH State Health Commissioner.
Attributes MHSPHPPPM Dysplasia Patient TrackingNoYes Peer (PCM) Review TrackingNoYes Referral Management System with Reports NoYes View upcoming Clinic.
Using Antibiotics Wisely Team Lead Call #6 Diane Liu, MD Assistant Professor, Pediatrics Co-Director, UPIQ.
Managed Care Nursing Facility Quality Initiatives February 2, 2015.
Free Powerpoint Templates Page 1 Using Data to Guide Improvement Presented by: Brooke Thomas, Program Advisor February 28, 2013.
Date of download: 6/26/2016 From: Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Infections in the Veteran Population: A Cross-sectional.
Surveillance diagnoses 465.9URI 462Acute Pharyngitis 461.9Acute Sinusitis 466Acute Bronchitis 463Acute Tonsillitis Viral Infection 460Common Cold.
FIHN PCP Pod Meeting April 6, 2017.
Antibiotic use and bacterial complications following upper respiratory tract infections: a population based study.
If I Ran the Zoo: Quality Measures in Accountable Care and the Fit with Integrative Health and Medicine. Jim Whedon, DC, MS Research Working Group,
Basics of New PHASE Reporting
Best Practice: Urgent Care PQRS.
Attachment #1: Examples of Encounter Data
Effectiveness of Care Measures
HEDIS ® Measures & Tips: Behavioral Health
IBH, Cost (Risk Adjusted)
PRACTICE MANAGER MEETING Wednesday Jan. 10th 2018 Noon – 1:00PM
Outpatient Antibiotic Prescribing
1422 Pre- Diabetes and Undiagnosed HTN Measures
Defining Metric Improvement in the MidSouth PTN
Clinical Strategy & Measurement Initiative Group February 5, 2013
What healthcare services are covered by insurance?
3.7.1 Definition The percentage of Ontario men and women of screen-eligible age (ages 50-74), who have completed at least one FOBT in the prior two years.
Presentation transcript:

Monthly Metrics Forum February 2014 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection

Overview Appropriate testing for children with Pharyngitis Appropriate treatment for children with Upper Respiratory Infection Other Metrics major specification changes for 2014

Measurement Year Both measures look at a rolling 12 month period that ends 6 months prior to the metrics date Examples: – Metrics for 31 Dec 2013 look at episodes of care from 1 July 2012 – 30 Jun 2013 – Metrics for 31 Oct 2013 look at episodes of care from 1 May Apr 2013

APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS

Appropriate Testing Definition In the 12 month measurement period, the percentage of children 2–18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic and received a group A streptococcus (strep) test by 3 days after the encounter. A higher rate represents better performance (i.e., appropriate testing). 5

HEDIS Percentile Benchmarks Year 10th25th50th75th90th for for

Denominator Children age 2-18 who had an Outpatient or Emergency Department (ED) encounter in the last year for pharyngitis and were dispensed antibiotic medications on or up to 3 days after this episode of care date Patient must be continuously enrolled from 30 days prior to Episode date through 3 days after episode date 7

Denominator Exclusions Excludes encounters with any additional diagnoses Excludes patients who received antibiotics in the last 30 days Excludes patients who received antibiotics more than 30 days prior, but the script was still active on episode date Only patient’s earliest episode in measurement year counts

Age Clarification 2 years old by start date of measurement year Less than 19 by last date of measurement year So, if they child had an episode of care when they were 18, but turned 19 prior to the end of the measurement year, none of their episodes of care will be included

Qualifying encounters DescriptionCPT/E&M Codes Outpatient , , , , , , , , 99411,99412, 99420, Emergency Dept (*Do not include ED visits that result in an inpatient admission) DescriptionICD-9-CM Diagnosis Acute pharyngitis462 Acute tonsillitis463 Streptococcal sore throat034.0

NUMERATOR Of the denominator patients, the patients who had a streptococcus test in the 7 day period from 3 days prior to the episode through 3 days after Also pull by lab test name in CHCS CPT Codes Group A Streptococcus Tests 87070, 87071, 87081, 87430, , 87880

Patient list Will be a historical list that is not actionable, similar to Appropriate imaging with Low Back Pain

Children with Pharyngitis Metric Summary Only includes 2-18 yr olds’ outpatient/ED encounters with just 1 diagnosis AND had Antibiotics dispensed within 3 days after Compliance=patient has strep test Excludes kids already on antibiotics Only child’s first visit in the 12 month measurement period will count To improve: provider education on proper coding and treatment. Ensure coding compliance of testing.

Top Performing DMISs

APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)

Definition In the 12 month measurement period, the percentage of children 3 months–18 years of age who were given a diagnosis of upper respiratory infection (URI) and were NOT dispensed an antibiotic prescription on or 3 days after the visit.

CRITICAL UNDERSTANDING The calculation of this measure is reported as an inverted rate [1 – (numerator/eligible population)] A higher rate indicates appropriate treatment of children with URI (i.e., the proportion for whom antibiotics were not prescribed).

HEDIS Percentile Benchmarks Year 10th25th50th75th90th for for

Denominator Children age 3 months-18yo who had an Outpatient or ED encounter in the last year for URI Patient must be continuously enrolled from 30 days prior to Episode date through 3 days after episode date 19

Denominator Exclusions Excludes encounters with any additional diagnoses Exclude encounters where patient had a competing diagnosis on or 3 days after the episode date Excludes patients who received antibiotics in the last 30 days Excludes patients who received antibiotics more than 30 days prior, but the script was still active on episode date Only patient’s earliest episode in measurement year counts

Age Clarification 3 months old by start date of measurement year Less than 19 by last date of measurement year So, if they child had an episode of care when they were 18, but turned 19 prior to the end of the measurement year, none of their episodes of care will be included

Qualifying encounters DescriptionCPT/E&M Codes Outpatient , , , , , , , , 99411,99412, 99420, Emergency Dept (*Do not include ED visits that result in an inpatient admission) DescriptionICD-9-CM Diagnosis Acute nasopharyngitis (common cold) 460 URI465

Competing Diagnoses

NUMERATOR Of the denominator patients, identify the patients who were dispensed an antibiotic on the episode date or in the 3 days after Metric is an inverse calculation with higher score is better: 1 – (numerator/denominator)=score

Patient list Will be a historical list that is not actionable, similar to Appropriate imaging with Low Back Pain

Children with URI Treatment Metric Summary Only includes 3 months-18 yr olds’ outpatient/ED encounters with just 1 diagnosis Compliance= NO Antibiotics prescribed on episode date or the 3 days after Excludes patients already on antibiotics Excludes if competing diagnosis w/in 3 days after Counts only child’s 1st episode in measurement year To improve: provider education on proper coding and treatment

Top DMIS Performers

Significant 2014 HEDIS changes Cervical Cancer Screening – Women over 30 can have pap + HPV on same date every 5 yrs or pap every 3yrs Breast Cancer Screening – Age group with mammo – Metric looks for mammo in last 27 months not 24 Asthma changes how to count inhaler medication dispensing events – All inhaled meds dispensed on same date count as single dispensing event – 2013 counted each inhaler as a dispensing event – 4 dispensing events is a criteria that could place patient in denominator – Impact should be fewer non-asthmatics on metric/lists

Antidepressant Medication Management 2014 changes 2013 Same ICD9 codes Start with Earliest dx in 12 month identification period (IP) Initial Dispensing occur within 30 before to 14 days after initial dx Must have at least 1 er, 1 inpt or 2 outpt major depression dx in 12mon IP Negative med history of 90 days prior to 1st dispensing in IP Continuous enrollment of 90 days prior to 1st dispensing through 231 days after 2014 Same diagnoses Start with earliest antidepressant dispensing DX occur within 60 days before to 60 days after 1 st dispensing 1 outpt, er or inpt dx around 1 st dispensing will suffice Negative med history of 105 days prior to 1 st dispensing in IP Continuous enrollment of 105 days prior to 1 st dispensing through 231 days after Impact should be more accurate capture of initial dispensing event for patient (and not falsely identify as “newly treated” a patient several months into therapy who picked up refill a 1-2 weeks late)

Benchmarks 2014 Health Plan Measures MHSPHP Data Timeperiod Percentile10th25th50th75th90th10th25th50th75th90th Breast Cancer Screening Cervical Cancer Screening Colorectal Cancer Screening Comprehensive Diabetes Care Hemoglobin A1c (HbA1c testing) LDL-C screening LDL-C control <100 mg/dL HbA1c <=9.0% HbA1c Control <8% <7% for a selected population Use of Appropriate Medications for People with Asthma Chlamydia Screening in Women Cholesterol Management for Patients with Cardiovascular Conditions LDL-C screening LDL-C is controlled (<100mg/dL) Antidepressant Medication Management Effective Acute Phase Treatment Effective Continuation Phase Treatment Mental Health Follow-up After Hospitalization in 7 days in 30 days Well Child Visits <15 months (six or more well-child visits) Appropriate Testing for Children With Pharyngitis Appropriate Treatment for Children With Upper Respiratory Infection LBP 2013 Benchmarks: 90 th = 82.21% 75 th = 79.15% 2014: 90 th = 82.73% 75 th = 79.66%

Next month: 2014 updates